BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19150337)

  • 1. Dual effect of Platelet Factor 4 on the activities of Factor Xa.
    Fiore MM; Mackie IJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1072-5. PubMed ID: 19150337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex.
    Manithody C; Rezaie AR
    Biochemistry; 2005 Aug; 44(30):10063-70. PubMed ID: 16042383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM; Mackie IM
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.
    Rezaie AR; Yang L; Manithody C
    Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of exosite binding modulators in the inhibition of Fxa by TFPI.
    Peraramelli S; Thomassen S; Heinzmann A; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M; Rosing J
    Thromb Haemost; 2016 Mar; 115(3):580-90. PubMed ID: 26607136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide.
    Fiore MM; Kakkar VV
    Biochem Biophys Res Commun; 2003 Nov; 311(1):71-6. PubMed ID: 14575696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets.
    Stevic I; Chan HH; Chander A; Berry LR; Chan AK
    Thromb Haemost; 2013 Jun; 109(6):1016-24. PubMed ID: 23494009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
    Koklic T; Chattopadhyay R; Majumder R; Lentz BR
    Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed structural models of the prothrombinase (FXa-FVa) complex.
    Autin L; Steen M; Dahlbäck B; Villoutreix BO
    Proteins; 2006 May; 63(3):440-50. PubMed ID: 16437549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a heparin-binding protein on blood coagulation and platelet function.
    Kaiser P; Harenberg J; Walenga JM; Huhle G; Giese C; Prechel M; Hoppensteadt D; Fareed J
    Semin Thromb Hemost; 2001 Oct; 27(5):495-502. PubMed ID: 11668419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant activity in salivary glands of the insect vector Culicoides variipennis sonorensis by an inhibitor of factor Xa.
    Pérez de León AA; Valenzuela JG; Tabachnick WJ
    Exp Parasitol; 1998 Feb; 88(2):121-30. PubMed ID: 9538866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ixolaris: a factor Xa heparin-binding exosite inhibitor.
    Monteiro RQ; Rezaie AR; Ribeiro JM; Francischetti IM
    Biochem J; 2005 May; 387(Pt 3):871-7. PubMed ID: 15617517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation.
    Brufatto N; Nesheim ME
    J Biol Chem; 2001 May; 276(21):17663-71. PubMed ID: 11278943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.
    Yegneswaran S; Banerjee Y; Fernández JA; Deguchi H; Griffin JH
    PLoS One; 2015; 10(8):e0135025. PubMed ID: 26263376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of the antiheparin activity of platelet factor 4 by a monoclonal antibody.
    Saggin L; Cazzola F; Corona G; Salvatico E; Cella G; Prosdocimi M
    Thromb Haemost; 1992 Jan; 67(1):137-43. PubMed ID: 1377413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes.
    Newell-Caito JL; Laha M; Tharp AC; Creamer JI; Xu H; Maddur AA; Tans G; Bock PE
    J Biol Chem; 2011 Nov; 286(44):38286-38297. PubMed ID: 21911491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DX-9065a inhibition of factor Xa and the prothrombinase complex: mechanism of inhibition and comparison with therapeutic heparins.
    Rezaie AR
    Thromb Haemost; 2003 Jan; 89(1):112-21. PubMed ID: 12540961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.